EviCure Overview
EviCure is developing a novel extracellular vesicle (EV)--based platform technology for cancer treatment. EviCure leverages AI capabilities and sophisticated human cancer disease models for in-depth comparative analyses of various stem cell subpopulations and secreted EVs to achieve robust and specific anti-tumor effects against a wide range of solid tumors. In addition to their endogenous therapeutic effects, EviCure’s EVs can be used as vehicles for the targeted delivery of RNA-based therapies, peptides, and small therapeutic molecules. This combined approach generates EVs that target multiple oncogenic pathways associated with tumor growth, metastasis, and resistance to radiation and advanced treatments. EviCure has also developed a groundbreaking approach for the of scale up of EVs using artificial intelligence (AI) algorithms and biological sensors to produce EVs in a consistent and reproducible process maintaining their anti-tumor effects throughout the entire scale-up production. PL-Ex-1 is the first product on EviCure’s platform and is expected to become a leading EV treatment against lung cancer providing a safe, cost-effective, mutation-agnostic, and stage-independent treatment for different types of lung and other solid tumors.
Cumulative Funding Raised Over Time ($)
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $700K |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 3 |
| Investors | 1 |
Team Members
2
Employees: 1-10
Web & Social Links
Locations
Rehovot, Israel
Photos & Videos
No files yet
EviCure Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
BiologicalsCellsArtificial IntelligenceTags (4)
cancerpharmaceuticalscancer-therapybiotechnologyEviCure Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
EviCure Lifecycle
Cumulative Funding Raised Over Time
All Events
EviCure News
0 articlesNo news articles.
Employee Info
| Employees (range) | 1-10 |
| Exact count | 5 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
EviCure Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 76/100 |
| Missing | sector, homepage, video or image, news, markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516767019 |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wainscheinker@sncentral.org |
| Last update | 2024-05-21T00:00:00.000Z |
| Created | 2024-05-21T00:00:00.000Z |